Roche Acquires Insulin Patch Pump Maker Medingo For Up To $200 Mil.
This article was originally published in The Gray Sheet
Executive Summary
Roche Diagnostics is expanding its diabetes care portfolio with the acquisition of Medingo Ltd., maker of the Solo micro insulin patch pump, for up to $200 million
You may also be interested in...
Medtronic Diabetes Pipeline Includes Insulin Patch, Next-Gen CGM
Medtronic is aiming to submit a 510(k) application to FDA for its patch-based insulin delivery device by year-end, setting the stage for a mid-2010 U.S. launch
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.